Your browser doesn't support javascript.
loading
Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis.
Firouzi, Javad; Sotoodehnejadnematalahi, Fattah; Shokouhifar, Alireza; Rahimi, Mahsa; Sodeifi, Niloufar; Sahranavardfar, Parisa; Azimi, Masoumeh; Janzamin, Ehsan; Safa, Majid; Ebrahimi, Marzieh.
Afiliación
  • Firouzi J; Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Sotoodehnejadnematalahi F; Cellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, Iran.
  • Shokouhifar A; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16635-148.
  • Rahimi M; Department of Biology, School of Basic Science, Science and Research Branch, Islamic Azad University, 1477893855.
  • Sodeifi N; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16635-148.
  • Sahranavardfar P; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16635-148.
  • Azimi M; Department of Pathology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran 16635-148, Iran.
  • Janzamin E; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16635-148.
  • Safa M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16635-148.
  • Ebrahimi M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16635-148.
Bioimpacts ; 12(5): 415-429, 2022.
Article en En | MEDLINE | ID: mdl-36381630

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Bioimpacts Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Bioimpacts Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán